CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) | Total | Common Stock | Additional Paid in Capital | Accumulated Deficit | Accumulated Other Comprehensive Income (Loss) |
Beginning balance (in shares) at Dec. 31, 2020 | | 98,035,829 | | | |
Beginning balance at Dec. 31, 2020 | $ 25,289,114 | $ 98,036 | $ 161,541,448 | $ (136,350,370) | |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | | |
Net loss | (2,147,268) | | | (2,147,268) | |
Stock-based compensation | 394,870 | | 394,870 | | |
Stock issued for vested restricted stock awards (in shares) | | 1,467,465 | | | |
Stock issued for vested restricted stock awards | 0 | $ 1,467 | (1,467) | | |
Shares withheld for taxes on vested restricted stock | (161,244) | | (161,244) | | |
Proceeds from exercise of options | 1,569 | | 1,569 | | |
Sale of common stock, net (in shares) | | 19,015,151 | | | |
Sale of common stock, net | 13,137,500 | $ 19,016 | 13,118,484 | | |
Ending balance (in shares) at Mar. 31, 2021 | | 118,518,445 | | | |
Ending balance at Mar. 31, 2021 | 36,514,541 | $ 118,519 | 174,893,660 | (138,497,638) | |
Beginning balance (in shares) at Dec. 31, 2020 | | 98,035,829 | | | |
Beginning balance at Dec. 31, 2020 | 25,289,114 | $ 98,036 | 161,541,448 | (136,350,370) | |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | | |
Net loss | (6,359,663) | | | | |
Unrealized gain (loss) on debt securities | 0 | | | | |
Ending balance (in shares) at Sep. 30, 2021 | | 118,747,447 | | | |
Ending balance at Sep. 30, 2021 | 33,369,062 | $ 118,748 | 175,960,347 | (142,710,033) | |
Beginning balance (in shares) at Mar. 31, 2021 | | 118,518,445 | | | |
Beginning balance at Mar. 31, 2021 | 36,514,541 | $ 118,519 | 174,893,660 | (138,497,638) | |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | | |
Net loss | (2,382,127) | | | (2,382,127) | |
Stock-based compensation | 557,602 | | 557,602 | | |
Ending balance (in shares) at Jun. 30, 2021 | | 118,518,445 | | | |
Ending balance at Jun. 30, 2021 | 34,690,016 | $ 118,519 | 175,451,262 | (140,879,765) | |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | | |
Net loss | (1,830,268) | | | (1,830,268) | |
Unrealized gain (loss) on debt securities | 0 | | | | |
Stock-based compensation | 613,544 | | 613,544 | | |
Stock issued for vested restricted stock awards (in shares) | | 229,002 | | | |
Stock issued for vested restricted stock awards | 0 | $ 229 | (229) | | |
Shares withheld for taxes on vested restricted stock | (110,805) | | (110,805) | | |
Stock warrants issued for referral agreement | 6,575 | | 6,575 | | |
Ending balance (in shares) at Sep. 30, 2021 | | 118,747,447 | | | |
Ending balance at Sep. 30, 2021 | 33,369,062 | $ 118,748 | 175,960,347 | (142,710,033) | |
Beginning balance (in shares) at Dec. 31, 2021 | | 118,747,447 | | | |
Beginning balance at Dec. 31, 2021 | 32,807,995 | $ 118,748 | 176,586,529 | (143,951,019) | $ 53,737 |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | | |
Net loss | (2,089,263) | | | (2,089,263) | |
Unrealized gain (loss) on debt securities | (98,156) | | | | (98,156) |
Stock-based compensation | 671,158 | | 671,158 | | |
Stock issued for vested restricted stock awards (in shares) | | 1,059,755 | | | |
Stock issued for vested restricted stock awards | 0 | $ 1,060 | (1,060) | | |
Shares withheld for taxes on vested restricted stock | (128,520) | | (128,520) | | |
Stock warrants issued for referral agreement | 12,483 | | 12,483 | | |
Ending balance (in shares) at Mar. 31, 2022 | | 119,807,202 | | | |
Ending balance at Mar. 31, 2022 | 31,175,697 | $ 119,808 | 177,140,590 | (146,040,282) | (44,419) |
Beginning balance (in shares) at Dec. 31, 2021 | | 118,747,447 | | | |
Beginning balance at Dec. 31, 2021 | 32,807,995 | $ 118,748 | 176,586,529 | (143,951,019) | 53,737 |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | | |
Net loss | (9,129,756) | | | | |
Unrealized gain (loss) on debt securities | (186,239) | | | | |
Ending balance (in shares) at Sep. 30, 2022 | | 120,137,124 | | | |
Ending balance at Sep. 30, 2022 | 25,214,581 | $ 120,138 | 178,307,716 | (153,080,771) | (132,502) |
Beginning balance (in shares) at Mar. 31, 2022 | | 119,807,202 | | | |
Beginning balance at Mar. 31, 2022 | 31,175,697 | $ 119,808 | 177,140,590 | (146,040,282) | (44,419) |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | | |
Net loss | (3,229,927) | | | (3,229,927) | |
Unrealized gain (loss) on debt securities | (124,253) | | | | (124,253) |
Stock-based compensation | 684,376 | | 684,376 | | |
Stock issued for vested restricted stock awards (in shares) | | 66,666 | | | |
Stock issued for vested restricted stock awards | 0 | $ 66 | (66) | | |
Stock warrants issued for referral agreement | 462 | | 462 | | |
Ending balance (in shares) at Jun. 30, 2022 | | 119,873,868 | | | |
Ending balance at Jun. 30, 2022 | 28,506,355 | $ 119,874 | 177,825,362 | (149,270,209) | (168,672) |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | | |
Net loss | (3,810,562) | | | (3,810,562) | |
Unrealized gain (loss) on debt securities | 36,170 | | | | 36,170 |
Stock-based compensation | 535,458 | | 535,458 | | |
Stock issued for vested restricted stock awards (in shares) | | 263,256 | | | |
Stock issued for vested restricted stock awards | 0 | $ 264 | (264) | | |
Shares withheld for taxes on vested restricted stock | (68,372) | | (68,372) | | |
Stock warrants issued for referral agreement | 15,532 | | 15,532 | | |
Ending balance (in shares) at Sep. 30, 2022 | | 120,137,124 | | | |
Ending balance at Sep. 30, 2022 | $ 25,214,581 | $ 120,138 | $ 178,307,716 | $ (153,080,771) | $ (132,502) |